
Peptide Therapeutics Forum 2025
5.-6. June 2025, Biozentrum Basel

Peptide Therpaeutics Forum 2025
5.- 6. June 2025, Biozentrum Basel
Peptide Therapeutics Forum 2025
5.-6. June 2025, Biozentrum Basel
Peptide Therpaeutics Forum 2025
5.- 6. June 2025, Biozentrum Basel
Thursday, June 5, 2025
Chair: Roderich Süssmuth, TU Berlin
09.00
Prof. Jeffrey Bode, ETH Zurich
«Synthetic and Medicinal Chemistry for Biologics»
11.00
11.30
Dr. Ilke Ugur Marion, Meddenvo Drug Design
«Computational Approaches to Bridge Linear and Cyclic Peptides in Drug Discovery»
12.00
Prof. Yftah Tal-Gan, University of Nevada
«Developing Peptide-Based Tools to Study Cell-Cell Communication in Bacteria»
12.30
Lunch Break and Poster Session
Chair: Thomas Vorherr, TU Berlin
14.00
4 Contributed lectures à 12min
Sangram Kale, Biosynth B.V.
«Targeted Radiotherapy using CLIPS™ Macrocyclic Peptides»
Hans Melo, Menten AI
«De Novo Design of Oral and Cell-permeable Peptides using Generative AI»
Sunay V. Chankeshwara, AstraZeneca
«On-Resin Parallel Synthesis and Evaluation of Stapled Oligopeptides: Advancing Macrocyclic Peptide Libraries»
Christian Behn, CEM
«Massive Waste Reduction for Solid Phase Peptide Synthesis»
16.30
Dr. Thomas Reiner, Evergreen Theragnostics
«Drug discovery in the age of radioligand therapies - and industry perspective»
17.00
18.00
Friday, June 6, 2025
Chair: Nathalie Grob, ETH Zurich
08.45
Prof. Markus Weingarth, Utrecht University
«Cracking Nature’s Recipes to Design Lipid-Targeting Antibiotics»
Dr. Kazuhiko Nakano, Chugai Pharmabody Research PTE. Ltd.
«Platform for Discovery of Orally Bioavailable Peptides for Intracellular Targets- From Hit Generation to a Clinical KRas Inhibitor»
10.30
11.00
Prof. Christian Heinis, EPFL Lausanne
«Membrane-permeable cyclic peptides for intracellular targets and oral delivery»
11.30
Prof. Ines Neundorf, University of Köln
«Tailor-made cell-penetrating peptides with various activity spectra»
12.00
4 Contributed lectures à 10min
Adeline Schmitt, ETH Zurich
«Nuclear Delivery of Inositol Pyrophosphate Prometabolites Mediated by Short Cationic Peptides»
Mirja Harms, University of Ulm
«GPR15LG and its derived peptides for the modulation of CXCR4 signaling»
Miroslava Nedyalkova, University of Fribourg
«Next-Gen Antibiotics: Metal-Boosted Nisin to Halt AMR»
Moritz List, University of Leipzig
«Cytosolic delivery of therapeutic peptides based on receptor-mediated endocytosis»
Stephanie Vogt, University of Basel
«Development of Next-Generation Compstatin Analogs with Enhanced Target Residence Time Enables New Applications»
13.00
Lunch Break and Poster Session
Chair: Thomas Vorherr, TU Berlin
14.30
Dr. Michael Wagner, Dewpoint Therapeutics
«Affibodies for PET imaging of active fibrosis»
15.00
Dr. Rami Hannoush, Versant Ventures
«Peptide Therapeutics for Tissue Regeneration»
15.30
16.00
Dr. Alexei Karpov, Novartis
«FXX489, a FAP targeting ligand with best-in-class potential for Radioligand Therapy»
16.30
16.50
Closing remarks & End of conference